BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9700724)

  • 21. In vivo antitumor effects of monoclonal antibodies with different immunoglobulin classes.
    Seto M; Takahashi T; Nakamura S; Matsudaira Y; Nishizuka Y
    Cancer Res; 1983 Oct; 43(10):4768-73. PubMed ID: 6192909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effector mechanism in antitumor activity of monoclonal antibodies produced against an ascitic mouse mammary tumor.
    Seto M; Takahashi T; Nakamura S; Saito M; Hara T; Nishizuka Y
    Cancer Res; 1986 Apr; 46(4 Pt 2):2056-61. PubMed ID: 3004718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.
    Bianco C; Bianco R; Tortora G; Damiano V; Guerrieri P; Montemaggi P; Mendelsohn J; De Placido S; Bianco AR; Ciardiello F
    Clin Cancer Res; 2000 Nov; 6(11):4343-50. PubMed ID: 11106252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice.
    Ran S; He J; Huang X; Soares M; Scothorn D; Thorpe PE
    Clin Cancer Res; 2005 Feb; 11(4):1551-62. PubMed ID: 15746060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocyte-colony stimulating factor enhances chimeric antibody Nd2 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils.
    Tamamori Y; Sawada T; Nishihara T; Yamashita Y; Ohira M; Ho JJ; Kim YS; Hirakawa-Y S Chung K
    Int J Oncol; 2002 Sep; 21(3):649-54. PubMed ID: 12168113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino acid residues that influence Fc epsilon RI-mediated effector functions of human immunoglobulin E.
    Sayers I; Cain SA; Swan JR; Pickett MA; Watt PJ; Holgate ST; Padlan EA; Schuck P; Helm BA
    Biochemistry; 1998 Nov; 37(46):16152-64. PubMed ID: 9819207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.
    Goldstein NI; Prewett M; Zuklys K; Rockwell P; Mendelsohn J
    Clin Cancer Res; 1995 Nov; 1(11):1311-8. PubMed ID: 9815926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocytes bearing Fc receptor for IgE. VIII. Affinity of mouse IgE for Fc epsilon R on Mouse B lymphocytes.
    Vander-Mallie R; Ishizaka T; Ishizaka K
    J Immunol; 1982 May; 128(5):2306-12. PubMed ID: 6977592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors.
    Goya M; Miyamoto S; Nagai K; Ohki Y; Nakamura K; Shitara K; Maeda H; Sangai T; Kodama K; Endoh Y; Ishii G; Hasebe T; Yonou H; Hatano T; Ogawa Y; Ochiai A
    Cancer Res; 2004 Sep; 64(17):6252-8. PubMed ID: 15342412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low and high tenascin-expressing tumors are efficiently targeted by ST2146 monoclonal antibody.
    De Santis R; Albertoni C; Petronzelli F; Campo S; D'Alessio V; Rosi A; Anastasi AM; Lindstedt R; Caroni N; Arseni B; Chiodi P; Verdoliva A; Cassani G; Chinol M; Paganelli G; Carminati P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2191-6. PubMed ID: 16609034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD23/IgE-mediated regulation of the specific antibody response in vivo.
    Gustavsson S; Hjulström S; Liu T; Heyman B
    J Immunol; 1994 May; 152(10):4793-800. PubMed ID: 8176203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgEs targeted on tumor cells: therapeutic activity and potential in the design of tumor vaccines.
    Reali E; Greiner JW; Corti A; Gould HJ; Bottazzoli F; Paganelli G; Schlom J; Siccardi AG
    Cancer Res; 2001 Jul; 61(14):5517-22. PubMed ID: 11454701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
    Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
    Cheung NK; Modak S
    Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of an in vitro method for the measurement of specific IgE antibody responses: the rat basophilic leukemia (RBL) cell assay.
    Dearman RJ; Skinner RA; Deakin N; Shaw D; Kimber I
    Toxicology; 2005 Jan; 206(2):195-205. PubMed ID: 15588913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic potential of humanized anti-interleukin-6 receptor antibody: antitumor activity in xenograft model of multiple myeloma.
    Tsunenari T; Akamatsu K; Kaiho S; Sato K; Tsuchiya M; Koishihara Y; Kishimoto T; Ohsugi Y
    Anticancer Res; 1996; 16(5A):2537-44. PubMed ID: 8917348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo enhancement of the specific antibody response via the low-affinity receptor for IgE.
    Heyman B; Tianmin L; Gustavsson S
    Eur J Immunol; 1993 Jul; 23(7):1739-42. PubMed ID: 8325347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
    Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ
    Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An unmodified anticarcinoma antibody, BR96, localizes to and inhibits the outgrowth of human tumors in nude mice.
    Schreiber GJ; Hellström KE; Hellström I
    Cancer Res; 1992 Jun; 52(12):3262-6. PubMed ID: 1596883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunoscintigraphy of anti-type IV collagenase monoclonal antibody in nude mice bearing human lung cancer xenograft].
    Dai Y; Jia B; Wang F; Du J; Shang BY; Zhen YS
    Ai Zheng; 2003 Dec; 22(12):1243-8. PubMed ID: 14693044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.